It contrasts with the FDA’s more restrictive approach to other products, including vaccines.
WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval for new drugs, the latest change from Trump administration officials vowing to speed up the availability of certa... [4459 chars]